German Chemical Industry (BASF/Bayer/Hoechst, 1865)

Class card for the German chemical-industry complex anchored by three founding firms: BASF (Badische Anilin- und Sodafabrik, founded 6 April 1865 by Friedrich Engelhorn at Ludwigshafen), Bayer (founded 1 August 1863 at Wuppertal by Friedrich Bayer and Johann Friedrich Weskott), and Hoechst (Farbwerke Hoechst, founded 2 January 1863 near Frankfurt). The machine's founding motor is the Liebig research-chemistry revolution: Justus von Liebig at Giessen (1825–1852) established the research-teaching laboratory model and trained August Wilhelm von Hofmann, who trained William Henry Perkin. Perkin's accidental synthesis of mauveine (aniline purple, 1856) opened the synthetic-dye market; German firms rapidly dominated, capturing ~85% of global synthetic dye production by 1900 through systematic university-industry coupling that translated Liebig-lineage organic chemistry into industrial throughput. The machine operates as a tep3-era push complex: coal-tar feedstocks from coking ovens feed dyestuff synthesis (alizarin BASF/Hoechst 1869; azo dyes; indigo BASF 1897); the industrial-patent system codifies proprietary routes; the Humboldtian research university provides trained chemists via the Liebig-Hofmann-Kekule lineage. Aspirin (acetylsalicylic acid) synthesized at Bayer by Felix Hoffmann 1897 and commercialized 1899 — the paradigm pharmaceutical output. Fritz Haber and Carl Bosch develop the Haber-Bosch ammonia synthesis process 1909–1913 (patented 1910; Nobel: Haber 1918, Bosch 1931), transforming agricultural nitrogen fixation and explosives production. By 1914 Germany produces ~90% of world's synthetic dyes and dominates the pharmaceutical and fertilizer markets. WWI: Fritz Haber directs Germany's chemical warfare program (chlorine gas, First Ypres 22 April 1915; phosgene 1916; mustard gas 1917). Versailles Treaty 1919 confiscates German chemical patents, transferring them to Allied firms (DuPont, Allied Chemical, ICI) — a direct Wallerstein-position assault on German chemical-industry OPP. IG Farben (Interessen-Gemeinschaft Farbenindustrie AG) formed 1925 by merger of BASF, Bayer, Hoechst, Agfa, Casella, and Weiler-ter-Meer as a defensive cartel after patent loss. Under National Socialism: IG Farben builds the Buna-N synthetic rubber plant at Auschwitz (1941–1945) using Auschwitz concentration camp slave labor; Degesch (controlled by IG Farben shareholder firms) produces Zyklon B. IG Farben Nuremberg trial (Case 6, 1947–1948): 23 executives indicted; 13 convicted of war crimes. Allied breakup 1951–1952: IG Farben dissolved into BASF, Bayer, Hoechst (Farbwerke Hoechst AG), Agfa, and smaller successors. Post-1951: BASF, Bayer, and Hoechst reconstitute as modern chemical-pharmaceutical firms. Hoechst merges with Rhône-Poulenc to form Aventis 1999, acquired by Sanofi 2004 (now Sanofi). BASF remains the world's largest chemical company by revenue (~$90B in 2024). Bayer acquires Monsanto 2018 ($63B) — a cross-era move into agri-biotech. BioNTech, founded 2008 in Mainz by Uğur Şahin and Özlem Türeci, is the modern descendant in pharma lineage: mRNA vaccine platform. The machine is an energetic_zombie in 2026 per atlas MM-06: BASF and Bayer persist at high energy and revenue but the original German-chemical-monopoly operational grammar (coal-tar → university-industry coupling → global dye+pharma dominance) ended with WWI Versailles patent confiscation and post-WWII restructuring. [CANON] claims: BASF 1865 founding; Bayer 1863 founding; Hoechst 1863 founding; Liebig Giessen 1825; Perkin mauveine 1856; alizarin 1869; Haber-Bosch 1909-1913; aspirin 1897; Ypres chlorine April 1915; IG Farben 1925; Auschwitz Buna plant; Zyklon B Degesch; Nuremberg Case 6; Allied breakup 1951; BASF $90B revenue 2024; Bayer-Monsanto 2018. [EXTRAP] claims: cross-era coupling strengths to mRNA platform and OpenAI (structural inference, not directly documented).